While explants of IH treated with an ACE or AT2R antagonist demonstrate a significant reduction in the nuclear expression of Ki67, a marker of cellular proliferation, the addition of an AT2R agonist increases the number of Ki67+ cells (90). This evidence concerns the gene MKI67 and isolated hemihyperplasia.